Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol dose-response in wheezy preschool children (DORESI)
NCT01470755Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salbutamol in asthma, sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2012; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01470755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470755.